Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P DUNN

Showing results (551-560 of 713) with videos related to

Pageof 72
Sort By:
American Journal of Ophthalmology|September 1, 2012
Wide-field retinal imaging in the management of noninfectious posterior uveitisJohn Peter Campbell, Henry Alexander Leder, Yasir Jamal Sepah, et al.
The New England Journal of Medicine|June 24, 2024
Tirzepatide for the Treatment of Obstructive Sleep Apnea and ObesityAtul Malhotra, Ronald R Grunstein, Ingo Fietze, et al.
American Journal of Epidemiology|November 11, 2003
Waist-to-hip ratio and breast cancer mortalityMarilyn J Borugian, Samuel B Sheps, Charmaine Kim-Sing, et al.
Journal of Ophthalmic Inflammation and Infection|September 11, 2016
Morphological assessment of the retina in uveitisMichael M Altaweel, Sapna S Gangaputra, Jennifer E Thorne, et al.
Bioorganic & Medicinal Chemistry Letters|November 11, 2008
Orally bioavailable prodrugs of a BCS class 2 molecule, an inhibitor of HIV-1 reverse transcriptaseTodd R Elworthy, James P Dunn, J Heather Hogg, et al.
Journal of Ophthalmic Inflammation and Infection|March 22, 2013
Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE StudyQuan Dong Nguyen, Mohamed A Ibrahim, Anthony Watters, et al.
Diabetes, Obesity & Metabolism|February 4, 2026
A treat-to-target approach for obesity management: A post hoc analysis of the SURMOUNT-5 trialCarel W le Roux, Luca Busetto, Louis Aronne, et al.
The Journal of Experimental Medicine|September 21, 2011
Type I interferon is selectively required by dendritic cells for immune rejection of tumorsMark S Diamond, Michelle Kinder, Hirokazu Matsushita, et al.
Ocular Immunology and Inflammation|February 21, 2023
Glaucoma Surgical Outcomes in Patients with a History of ScleritisJae-Chiang Wong, Esika Savsani, Raziyeh Mahmoudzadeh, et al.
Ophthalmology. Retina|June 30, 2020
Endophthalmitis after Cataract Surgery: Changes in Management Based on Microbiologic CulturesSamir N Patel, Philip P Storey, Hannah Levin, et al.
Pageof 72

Showing results (551-560 of 713) with videos related to

Sort By:
Pageof 72
American Journal of Ophthalmology|September 1, 2012
Wide-field retinal imaging in the management of noninfectious posterior uveitisJohn Peter Campbell, Henry Alexander Leder, Yasir Jamal Sepah, et al.
The New England Journal of Medicine|June 24, 2024
Tirzepatide for the Treatment of Obstructive Sleep Apnea and ObesityAtul Malhotra, Ronald R Grunstein, Ingo Fietze, et al.
American Journal of Epidemiology|November 11, 2003
Waist-to-hip ratio and breast cancer mortalityMarilyn J Borugian, Samuel B Sheps, Charmaine Kim-Sing, et al.
Journal of Ophthalmic Inflammation and Infection|September 11, 2016
Morphological assessment of the retina in uveitisMichael M Altaweel, Sapna S Gangaputra, Jennifer E Thorne, et al.
Bioorganic & Medicinal Chemistry Letters|November 11, 2008
Orally bioavailable prodrugs of a BCS class 2 molecule, an inhibitor of HIV-1 reverse transcriptaseTodd R Elworthy, James P Dunn, J Heather Hogg, et al.
Journal of Ophthalmic Inflammation and Infection|March 22, 2013
Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE StudyQuan Dong Nguyen, Mohamed A Ibrahim, Anthony Watters, et al.
Diabetes, Obesity & Metabolism|February 4, 2026
A treat-to-target approach for obesity management: A post hoc analysis of the SURMOUNT-5 trialCarel W le Roux, Luca Busetto, Louis Aronne, et al.
The Journal of Experimental Medicine|September 21, 2011
Type I interferon is selectively required by dendritic cells for immune rejection of tumorsMark S Diamond, Michelle Kinder, Hirokazu Matsushita, et al.
Ocular Immunology and Inflammation|February 21, 2023
Glaucoma Surgical Outcomes in Patients with a History of ScleritisJae-Chiang Wong, Esika Savsani, Raziyeh Mahmoudzadeh, et al.
Ophthalmology. Retina|June 30, 2020
Endophthalmitis after Cataract Surgery: Changes in Management Based on Microbiologic CulturesSamir N Patel, Philip P Storey, Hannah Levin, et al.
Pageof 72